S.E.S Shoulder Arthroplasty Data Collection

March 6, 2017 updated by: Zimmer Biomet

A Prospective, Multicentre Study Evaluating the Clinical Performance of the S.E.S Shoulder Prosthesis

This observational study intends to collect efficacy and safety data on S.E.S shoulder system

Study Overview

Status

Terminated

Conditions

Detailed Description

The S.E.S.® shoulder system has been developed to provide a complete solution for all the indications for Shoulder Arthroplasty, Arthritis, Rotator Cuff Arthropathy, Proximal Humeral Fracture, minimising bone resection and restoring the natural anatomy of the patient.

Study Type

Observational

Enrollment (Actual)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Schilde, Belgium
        • De Dreef Van Zonnebos 13
      • Annecy, France
        • Clinique Générale
      • Chambery, France
        • Clinique St Joseph
      • Dax, France
        • Centre Hospitalier General
      • Maxeville, France
        • Clinique Chirurgicale Orthopédique A.D.R.
      • Montpellier, France
        • Clinique St Jean
      • Paris, France
        • IRCOS
      • Pessac, France
        • Clinique St Martin
      • Saint Herblain, France
        • Polyclinique de l'Atlantique
      • St Etienne, France
        • Clinique Mutualiste
      • St Laurent du Var, France
        • Institut A. Tzanck
      • St Laurent du Var, France
        • Institut Calot

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Consecutive series of patients received S.E.S prostheses

Description

Inclusion Criteria:

  • A pre-operative level of pain and function the same as for conventional joint replacement
  • A likelihood of obtaining relief of pain and improved function
  • Full skeletal maturity
  • Ability to follow instructions
  • Good general health for age
  • Willing to return for follow-up evaluations

Exclusion Criteria:

  • Glenohumeral joint infection, osteomyelitis
  • Neuro-muscular complications
  • Inability to co-operate with and complete the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
S.E.S prosthesis
Consecutive series of patients with a S.E.S prosthesis.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Constance and oxford Scores
Time Frame: 6m, 1yr, 2yr, 3yr, 4yr and 5 yr
6m, 1yr, 2yr, 3yr, 4yr and 5 yr

Secondary Outcome Measures

Outcome Measure
Time Frame
Complication
Time Frame: Any time
Any time
Patient Satisfaction
Time Frame: 6m,1yr,2yr,3yr,4yr and 5yr
6m,1yr,2yr,3yr,4yr and 5yr

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Principal Investigator: Laurent BEGUIN, MD, Centre hospitalier Bellevue

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2003

Primary Completion (Actual)

September 1, 2016

Study Completion (Actual)

September 1, 2016

Study Registration Dates

First Submitted

September 16, 2008

First Submitted That Met QC Criteria

September 17, 2008

First Posted (Estimate)

September 18, 2008

Study Record Updates

Last Update Posted (Actual)

March 7, 2017

Last Update Submitted That Met QC Criteria

March 6, 2017

Last Verified

March 1, 2017

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • BMET FR 02

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Arthritis

3
Subscribe